Preparation of acylated indoline and tetrahydroquinoline derivatives as hepatitis C virus (HCV) inhibitors.

Autoria(s): Bravi, G.; Grimes, R.M.; Guidetti, R.; Haigh, David; Hartley, C.D.; Mordaunt, J.E.; Shah, P.; Slater, M.J.
Data(s)

01/11/2004
Identificador

http://pure.qub.ac.uk/portal/en/publications/preparation-of-acylated-indoline-and-tetrahydroquinoline-derivatives-as-hepatitis-c-virus-hcv-inhibitors(c62bbd4a-8d05-4e5c-b2c1-774579b7372a).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Bravi , G , Grimes , R M , Guidetti , R , Haigh , D , Hartley , C D , Mordaunt , J E , Shah , P & Slater , M J 2004 , Preparation of acylated indoline and tetrahydroquinoline derivatives as hepatitis C virus (HCV) inhibitors. , Patent No. WO 2004096210 A1 .
Tipo

patent
Acesso ao item digital